REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 174 filers reported holding REATA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $596,976 | +19.8% | 5,855 | +6.9% | 0.00% | 0.0% |
| Q1 2023 | $498,151 | +112.1% | 5,479 | -11.4% | 0.00% | +100.0% |
| Q4 2022 | $234,854 | -14.9% | 6,182 | -26.5% | 0.00% | 0.0% |
| Q1 2022 | $276,000 | +0.4% | 8,407 | -19.4% | 0.00% | 0.0% |
| Q4 2021 | $275,000 | -73.3% | 10,428 | +1.9% | 0.00% | -66.7% |
| Q3 2021 | $1,030,000 | -43.0% | 10,238 | -19.8% | 0.00% | -40.0% |
| Q2 2021 | $1,806,000 | +322.0% | 12,759 | +197.3% | 0.01% | +400.0% |
| Q1 2021 | $428,000 | -22.2% | 4,291 | -3.6% | 0.00% | -50.0% |
| Q4 2020 | $550,000 | +22.8% | 4,451 | -3.3% | 0.00% | 0.0% |
| Q3 2020 | $448,000 | -36.2% | 4,602 | +2.3% | 0.00% | -50.0% |
| Q2 2020 | $702,000 | -4.9% | 4,500 | -12.0% | 0.00% | -20.0% |
| Q1 2020 | $738,000 | -59.8% | 5,116 | -43.1% | 0.01% | -44.4% |
| Q4 2019 | $1,837,000 | +156.6% | 8,988 | +0.8% | 0.01% | +125.0% |
| Q3 2019 | $716,000 | -16.8% | 8,917 | -2.3% | 0.00% | -20.0% |
| Q2 2019 | $861,000 | -1.6% | 9,130 | -10.8% | 0.01% | 0.0% |
| Q1 2019 | $875,000 | +54.3% | 10,234 | +1.3% | 0.01% | +25.0% |
| Q4 2018 | $567,000 | -42.0% | 10,101 | -15.6% | 0.00% | -42.9% |
| Q3 2018 | $978,000 | +164.3% | 11,964 | +13.1% | 0.01% | +250.0% |
| Q2 2018 | $370,000 | +69.7% | 10,576 | -0.4% | 0.00% | +100.0% |
| Q1 2018 | $218,000 | -37.7% | 10,621 | -14.1% | 0.00% | -50.0% |
| Q4 2017 | $350,000 | – | 12,370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DekaBank Deutsche Girozentrale | 17,000 | $2,930 | 0.01% |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 93,711 | $1,612 | 0.00% |
| IFP Advisors, Inc | 300 | $51,708 | 0.00% |